Details for 2019153389
Up to date per 02.04.2026
Actions
Details for 2019153389
Granted/Registered
European Patent
24.07.2019 A
06.09.2023 B1
15.03.2013
US
201361791913 P
C07D 453/02 20060101AFI20220628BHEP
Owner
Genzyme Corporation450 Water Street Cambridge, MA 02141US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
SIEGEL, Craigc/o Sanofi U.S., 55 Corporate Drive Bridgewater, New Jersey 08807US
GIMI, Rayomandc/o Sanofi U.S., 55 Corporate Drive Bridgewater, New Jersey 08807US
REARDON, Michaelc/o Sanofi U.S., 55 Corporate Drive Bridgewater, New Jersey 08807US
ZHAO, Jinc/o Sanofi U.S., 55 Corporate Drive Bridgewater, New Jersey 08807US
Information about Fees